【4557】医学生物学研究所
〔上場廃止〕
臨床検査薬・研究用試薬。親会社はJSR。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021.03 | 2020/10/27 | Q2予 | 9,700 | ↑ | +3.7% | +3.7% | 1,800 | ↑ | +20.0% | +20.0% | 1,800 | ↑ | +16.1% | +16.1% | 1,550 | ↑ | +24.0% | +24.0% |
2021.03 | 2020/07/28 | Q1予 | 9,350 | → | 0.0% | 0.0% | 1,500 | → | 0.0% | 0.0% | 1,550 | → | 0.0% | 0.0% | 1,250 | → | 0.0% | 0.0% |
2021.03 | 2020/04/28 | 当初予 | 9,350 | - | - | - | 1,500 | - | - | - | 1,550 | - | - | - | 1,250 | - | - | - |
2020.03 | 2020/04/28 | 実 | 9,229 | ↓ | -0.8% | +7.3% | 1,334 | ↓ | -4.7% | +33.4% | 1,326 | ↑ | +2.0% | +32.6% | 1,266 | ↑ | +5.5% | +48.9% |
2020.03 | 2020/03/31 | 修正予 | 9,300 | → | 0.0% | +8.1% | 1,400 | → | 0.0% | +40.0% | 1,300 | → | 0.0% | +30.0% | 1,200 | ↑ | +9.1% | +41.2% |
2020.03 | 2020/01/28 | Q3予 | 9,300 | → | 0.0% | +8.1% | 1,400 | → | 0.0% | +40.0% | 1,300 | → | 0.0% | +30.0% | 1,100 | → | 0.0% | +29.4% |
2020.03 | 2019/10/29 | 修正予 | 9,300 | ↑ | +8.1% | +8.1% | 1,400 | ↑ | +40.0% | +40.0% | 1,300 | ↑ | +30.0% | +30.0% | 1,100 | ↑ | +29.4% | +29.4% |
2020.03 | 2019/07/30 | Q1予 | 8,600 | → | 0.0% | 0.0% | 1,000 | → | 0.0% | 0.0% | 1,000 | → | 0.0% | 0.0% | 850 | → | 0.0% | 0.0% |
2020.03 | 2019/04/23 | 当初予 | 8,600 | - | - | - | 1,000 | - | - | - | 1,000 | - | - | - | 850 | - | - | - |
2019.03 | 2019/04/23 | 実 | 8,182 | ↑ | +1.0% | +7.7% | 488 | ↑ | +22.0% | +112.2% | 552 | ↑ | +31.4% | +224.7% | 316 | ↑ | +97.5% | +110.7% |
2019.03 | 2019/03/28 | 修正予 | 8,100 | ↑ | +6.6% | +6.6% | 400 | ↑ | +73.9% | +73.9% | 420 | ↑ | +147.1% | +147.1% | 160 | ↑ | +362.3% | +6.7% |
2019.03 | 2019/01/29 | Q3予 | 7,600 | → | 0.0% | 0.0% | 230 | → | 0.0% | 0.0% | 170 | → | 0.0% | 0.0% | -61 | → | 0.0% | -140.7% |
2019.03 | 2018/11/16 | 修正予 | 7,600 | → | 0.0% | 0.0% | 230 | → | 0.0% | 0.0% | 170 | → | 0.0% | 0.0% | -61 | ↓ | -140.7% | -140.7% |
2019.03 | 2018/10/30 | Q2予 | 7,600 | → | 0.0% | 0.0% | 230 | → | 0.0% | 0.0% | 170 | → | 0.0% | 0.0% | 150 | → | 0.0% | 0.0% |
2019.03 | 2018/07/31 | Q1予 | 7,600 | → | 0.0% | 0.0% | 230 | - | - | - | 170 | → | 0.0% | 0.0% | 150 | → | 0.0% | 0.0% |
2019.03 | 2018/04/24 | 当初予 | 7,600 | - | - | - | - | - | - | - | 170 | - | - | - | 150 | - | - | - |
2018.03 | 2018/04/24 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
2018.03 | 2018/04/20 | 修正予 | 7,072 | ↓ | -0.4% | -0.4% | - | - | - | - | 11 | ↑ | +155.0% | +106.5% | -59 | ↑ | +41.0% | +68.8% |
2018.03 | 2018/01/30 | 修正予 | 7,100 | → | 0.0% | 0.0% | 50 | → | 0.0% | 0.0% | -20 | ↑ | +88.2% | +88.2% | -100 | ↑ | +47.1% | +47.1% |
2018.03 | 2017/10/27 | Q2予 | 7,100 | → | 0.0% | 0.0% | 50 | → | 0.0% | 0.0% | -170 | → | 0.0% | 0.0% | -189 | → | 0.0% | 0.0% |
2018.03 | 2017/07/25 | Q1予 | 7,100 | → | 0.0% | 0.0% | 50 | → | 0.0% | 0.0% | -170 | → | 0.0% | 0.0% | -189 | → | 0.0% | 0.0% |
2018.03 | 2017/04/25 | 当初予 | 7,100 | - | - | - | 50 | - | - | - | -170 | - | - | - | -189 | - | - | - |
2017.03 | 2017/04/25 | 実 | 7,348 | → | 0.0% | -1.1% | 85 | → | 0.0% | - | 64 | → | 0.0% | +146.2% | 188 | → | 0.0% | -36.7% |
2017.03 | 2017/04/20 | 修正予 | 7,348 | ↓ | -1.1% | -1.1% | 85 | ↑ | - | - | 64 | ↑ | +146.2% | +146.2% | 188 | ↓ | -36.7% | -36.7% |
2017.03 | 2017/01/24 | Q3予 | 7,430 | → | 0.0% | 0.0% | 0 | → | - | - | 26 | → | 0.0% | 0.0% | 297 | → | 0.0% | 0.0% |
2017.03 | 2016/10/28 | Q2予 | 7,430 | → | 0.0% | 0.0% | 0 | → | - | - | 26 | → | 0.0% | 0.0% | 297 | → | 0.0% | 0.0% |
2017.03 | 2016/04/28 | 当初予 | 7,430 | - | - | - | 0 | - | - | - | 26 | - | - | - | 297 | - | - | - |
2016.03 | 2016/04/28 | 実 | 8,056 | → | 0.0% | -11.3% | -368 | ↓ | -4.8% | -417.2% | -449 | ↓ | -0.4% | -497.3% | -1,142 | ↑ | +1.3% | -1412.6% |
2016.03 | 2016/04/19 | 修正予 | 8,056 | ↓ | -0.5% | -11.3% | -351 | ↓ | -8.3% | -402.6% | -447 | ↓ | -25.2% | -495.6% | -1,157 | ↑ | +3.6% | -1429.9% |
2016.03 | 2016/02/16 | 修正予 | 8,093 | ↓ | -10.9% | -10.9% | -324 | ↓ | -379.3% | -379.3% | -357 | ↓ | -415.9% | -415.9% | -1,200 | ↓ | -1479.3% | -1479.3% |
2016.03 | 2016/01/26 | Q3予 | 9,086 | → | 0.0% | 0.0% | 116 | → | 0.0% | 0.0% | 113 | → | 0.0% | 0.0% | 87 | → | 0.0% | 0.0% |
2016.03 | 2015/10/26 | Q2予 | 9,086 | → | 0.0% | 0.0% | 116 | → | 0.0% | 0.0% | 113 | → | 0.0% | 0.0% | 87 | → | 0.0% | 0.0% |
2016.03 | 2015/07/27 | Q1予 | 9,086 | → | 0.0% | 0.0% | 116 | - | - | - | 113 | → | 0.0% | 0.0% | 87 | → | 0.0% | 0.0% |
2016.03 | 2015/04/27 | 当初予 | 9,086 | - | - | - | - | - | - | - | 113 | - | - | - | 87 | - | - | - |
2015.03 | 2015/04/27 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
2015.03 | 2015/01/26 | Q3予 | 7,773 | → | 0.0% | -1.0% | -789 | → | 0.0% | -558.7% | -680 | → | 0.0% | -569.0% | -754 | → | 0.0% | -693.7% |
2015.03 | 2015/01/09 | 修正予 | 7,773 | ↓ | -1.0% | -1.0% | -789 | ↓ | -558.7% | -558.7% | -680 | ↓ | -569.0% | -569.0% | -754 | ↓ | -693.7% | -693.7% |
2015.03 | 2014/10/27 | Q2予 | 7,854 | → | 0.0% | 0.0% | 172 | → | 0.0% | 0.0% | 145 | → | 0.0% | 0.0% | 127 | → | 0.0% | 0.0% |
2015.03 | 2014/07/29 | Q1予 | 7,854 | → | 0.0% | 0.0% | 172 | → | 0.0% | 0.0% | 145 | → | 0.0% | 0.0% | 127 | → | 0.0% | 0.0% |
2015.03 | 2014/05/02 | 当初予 | 7,854 | - | - | - | 172 | - | - | - | 145 | - | - | - | 127 | - | - | - |
2014.03 | 2014/05/02 | 実 | 7,172 | → | 0.0% | -2.8% | -519 | → | 0.0% | -88.7% | -476 | → | 0.0% | -157.3% | -418 | → | 0.0% | -216.7% |
2014.03 | 2014/04/21 | 修正予 | 7,172 | ↓ | -2.8% | -2.8% | -519 | ↓ | -88.7% | -88.7% | -476 | ↓ | -157.3% | -157.3% | -418 | ↓ | -216.7% | -216.7% |
2014.03 | 2014/01/31 | 当初予 | 7,378 | - | - | - | -275 | - | - | - | -185 | - | - | - | -132 | - | - | - |